Coronavirus (COVID-19) Current Therapy Market Report 2020-2030 Trends And Strategies Analysis

The Business Research Company offers "Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

The global COVID-19 current therapy market is expected to grow from $10.83 billion in 2019 to $16.51 billion in 2020 at a compound annual growth rate (CAGR) of 52.5%. The growth is mainly attributed to the COVID-19 outbreak and the urgent need to treat the growing number of cases. With no effective therapeutics discovered so far, existing drugs such as Remdesivir, Hydroxychloroquine, Ritonavir, Lopinavir, Interferon Beta, among others are repurposed for the COVID-19 treatment. The market is then expected to stabilize and reach $27.27 billion in 2023 at a CAGR of 18.2%.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3247

The coronavirus (COVID-19) current therapy market consists of sales of drugs currently used for the treatment of COVID-19 infection. The market report includes single-drug therapeutics and combination drug therapeutics used in treating COVID-19 patients. The market consists of revenue generated by the companies that manufacture coronavirus current therapeutics by the sales of these products.

The outbreak of the pandemic COVID-19 contributed to the growth of coronavirus (COVID-19) current therapy market. On March 11, 2020, the World Health Organization (WHO) declared the outbreak as a global pandemic. According to the World Health Organization (WHO), there were 10,719,946 cases of COVID19 including 517,337 deaths reported to WHO as on 3rd July 2020, and this number is expected to grow soon. As there is no officially approved drug for COVID-19, the demand has risen significantly for repurposed drugs that are used for corona therapy. Countries across the world are facing shortages of drugs and the drug manufacturers are ramping up production to meet the global demand. Coronavirus Treatment Acceleration Program (CTAP) is a special emergency program initiated by the FDA for the development of potential COVID-19 therapies to be made available to the patients as quickly as possible.

Coronavirus (COVID-19) Current Therapy Market Segmentation: -
By Drug Type
Antiviral (Remdesivir; Ritonavir; Lopinavir)
Antimalarial (Hydroxychloroquine)
Interferons (Interferon Beta)
Corticosteroid (Dexamethasone)
Others

By End User
Hospitals
Clinics
Research Institutes
Others

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/coronavirus-covid-19-current-therapy-market-global-report-2020-covid-19-growth-and-change

Few Points From Table Of Content
1. Executive Summary
2. Coronavirus (COVID-19) Current Therapy Market Characteristics
3. Coronavirus (COVID-19) Current Therapy Market Size And Growth
4. Coronavirus (COVID-19) Current Therapy Market Segmentation
5. Coronavirus (COVID-19) Current Therapy Market Regional And Country Analysis
.
.
.
24. Africa Coronavirus (COVID-19) Current Therapy Market
25. Coronavirus (COVID-19) Current Therapy Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Coronavirus (COVID-19) Current Therapy Market
27. Coronavirus (COVID-19) Current Therapy Market Trends And Strategies
28. Coronavirus (COVID-19) Current Therapy Market Future Outlook and Potential Analysis
29. Appendix

The report covers the trends and market dynamics of the Coronavirus (COVID-19) Current Therapy Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp

Some of the key players involved in the Coronavirus (COVID-19) Current Therapy Market are Moderna Therapeutics, Novavax, Bravovax, Ascletis Pharma, Altimmune, Clover Biopharmaceuticals, Inovio Pharmaceuticals, Inc., Biocryst Pharma, Gilead Sciences, Regeneron Pharmaceuticals, Applied DNA Sciences, Inc, Codagenix, GeoVax Labs, Inc., Takis Biotech, Evvivax.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.